MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

April 2010


Drugs for Alzheimer’s Disease: Are They Effective?

Five medications have been approved for use in patients with Alzheimer’s disease; nonetheless, there remains an urgent need for new and effective drugs. This article describes the role of these agents, with an emphasis on their efficacy, effectiveness, costs, and associated controversies.
David A. Casey, MD, Demetra Antimisiaris, PharmD, and James O’Brien, MD

Bar-Code Scanning at Four Health Care Facilities in the U.S.

Hospital administrators are beginning to focus on bar-code scanning as a part of a multi-pronged strategy to reduce medication errors. The experience with bar-coding technology at four medical institutions is described.
Cindy H. Dubin

Blog Watch

Generic Drugs

Caveat Emptor! (and Other Advice from Cyberspace)

The decades-old debate over generic versus brand-name drugs, once mainly the stuff of medical journals, is now a hot topic on the blogosphere as well. The author provides a sampling of postings from bloggers.
Miriam Reisman

Pharmaceutical Approval Update

Topics include liraglutide injection (Victoza) for type-2 diabetes; Prevnar 13 vaccine for protection against invasive pneumococcal diseases in children; and olmesartan medoxomil (Benicar) for children with elevated blood pressure.
Marvin M. Goldenberg, PhD, RPh, MS

Continuing Education Credit

The Escalating Role of Epidermal Growth Factor Receptor Inhibitors in Cancer Management

Clinical Considerations for the Health System Pharmacist

Targeted therapies are improving outcomes in patients with colorectal, non–small-cell lung cancer, and pancreatic cancer. The authors evaluate the efficacy of these agents and suggest strategies for preventing and managing adverse effects from these treatments to ensure optimal patient care.
Dwight D. Kloth, PharmD, FCCP, BCOP; Lew Iacovelli, BS, PharmD, BCOP, CPP; Rebecca Arbuckle, MS, RPh; and Angela C. McIntosh, PhD



Increasing Patient and Family Engagement in Health Care

David B. Nash, MD, MBA, discusses the importance of engaging patients in their own health care.
David B. Nash, MD, MBA

Medication Errors

Rapid Response Teams in Hospitals Increase Patient Safety

Matthew Grissinger, RPh, FASCP, explains the value of rapid response teams in hospitals for facilitating patient safety and communication.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Definition of ‘Meaningful Use’ Poses Challenges for Hospitals

Meeting Criteria for Pharmacy Software and Electronic Medical Records Will Be Difficult

Stephen Barlas reviews the challenges facing hospitals as they begin to try to meet the basic definition of “meaningful use” and adopt electronic medical records.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From Exalgo to VPRIV, P&T presents the latest information about FDA approvals, drug indications, product recalls, and industry updates.

Drug Forecast

Pitavastatin (Livalo) for Hyperlipidemia And Mixed Dyslipidemia

A Novel Therapeutic Agent, or a ‘Me-Too’ Drug?

Pitavastatin (Livalo), a statin for hyperlipidemia and mixed dyslipidemia, is reviewed.
Timothy Reilly, PharmD, BCPS; George King; Jee Hye Park; and Amanda Tracy